Niosomes for nose-to-brain delivery: a non-invasive versatile carrier system for drug delivery in neurodegenerative diseases

AR Al Jayoush, HAFM Hassan, H Asiri, M Jafar… - Journal of Drug Delivery …, 2023 - Elsevier
Neurodegenerative diseases (NDDs) significantly contribute to morbidity and mortality
worldwide. The suboptimal effect of currently used therapeutic approaches administered via …

Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges

TTS Khan, Z Sheikh, S Maleknia, F Oveissi… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), approved by the US
FDA for obesity treatment, are typically administered subcutaneously, an invasive method …

Fructus Xanthii and Magnolia liliiflora Volatile Oils Liposomes-Loaded Thermosensitive in situ Gel for Allergic Rhinitis Management

Z Jing, W Li, W Liao, Y Lv, Y Liu, H Jiang… - International Journal of …, 2024 - Taylor & Francis
Purpose The aim of the present study was to fabricate a Fructus Xanthii and Magnolia
liliiflora volatile oils liposomes-loaded thermosensitive in situ gel (gel/LIP/volatile oil) for …

[HTML][HTML] Spanlastic Nano-Vesicles: A Novel Approach to Improve the Dissolution, Bioavailability, and Pharmacokinetic Behavior of Famotidine

HI Almohamady, Y Mortagi, S Gad, S Zaitone… - …, 2024 - pmc.ncbi.nlm.nih.gov
Background/Objectives: Drugs exhibiting poor aqueous solubility present a challenge to
efficient delivery to the site of action. Spanlastics (a nano, surfactant-based drug delivery …